Effect of antitubercular treatment on tumorous endobronchial tuberculosis.
Four cases of tumorous endobronchial tuberculosis (EBTB) were prospectively evaluated to assess the effect of antitubercular treatment (ATT) on tumorous EBTB. All 4 patients received standard ATT (isoniazid, rifampicin, ethambutol, and pyrizinamide for 2 months followed by isoniazid and rifampicin). At the completion of ATT, bronchoscopy was repeated in all cases and no residual structural abnormality of the bronchus was identified. Short-course ATT without corticosteroid is effective in preventing residual endobronchial complication of tumorous EBTB.